Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.46 |
| ▸ | MMP3 | P08254 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | KDM1A | O60341 | 1/20 | 0.44 |
| ▸ | HSD11B1 | P28845 | 4/20 | 0.42 |
| ▸ | AR | P10275 | 2/20 | 0.41 |
| ▸ | PLAU | P00749 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | RHEB | Q15382 | 1/20 | 0.41 |
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31263963 | 1.00 | KIF11 (0.46) | KIF11MMP3ALDH1A1CYP2A6KDM1A | |
| SCHEMBL30924148 | 0.84 | AR (0.54) | ALDH1A1CYP2A6HSD11B1ARCYP3A4 | |
| SCHEMBL171602 | 0.84 | AR (0.54) | ALDH1A1CYP2A6HSD11B1ARCYP3A4 | |
| SCHEMBL10304732 | 0.82 | KIF11 (0.50) | KIF11MMP3ALDH1A1CYP2A6HSD11B1 | |
| SCHEMBL12259927 | 0.81 | CYP3A4 (0.56) | ALDH1A1CYP3A4 | |
| SCHEMBL31463157 | 0.78 | MMP3 (0.47) | KIF11MMP3HSD11B1PLAURHEB | |
| SCHEMBL13906332 | 0.77 | AHR (0.56) | ALDH1A1CYP3A4 | |
| SCHEMBL13494487 | 0.77 | CYP3A4 (0.48) | ALDH1A1CYP3A4 | |
| SCHEMBL3468432 | 0.77 | KIF11 (0.46) | KIF11MMP3ALDH1A1CYP2A6HSD11B1 | |
| SCHEMBL31757686 | 0.77 | KIF11 (0.46) | KIF11MMP3ALDH1A1CYP2A6HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250242338-A1 | IRON PHOSPHIDE NANOPARTICLES, AND COMPOSITE BODY AND REDUCTION CATALYST EACH CONTAINING SAME | OSAKA UNIVERSITY (JP) | 2025-07-31 | — | — | US | disclosed |
| EP-4509462-A1 | IRON PHOSPHIDE NANOPARTICLES, AND COMPOSITE BODY AND REDUCTION CATALYST EACH CONTAINING SAME | OSAKA UNIVERSITY (JP) | 2025-02-19 | — | — | EP | disclosed |
| WO-2023200015-A1 | IRON PHOSPHIDE NANOPARTICLES, AND COMPOSITE BODY AND REDUCTION CATALYST EACH CONTAINING SAME | 国立大学法人大阪大学 | 2023-10-19 | — | — | WO | disclosed |
| US-9616037-B2 | Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use | PIMCO 2664 LIMITED (GB) | 2017-04-11 | — | — | US | disclosed |
| US-20160206578-A1 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use | PIMCO 2664 LIMITED (GB) | 2016-07-21 | — | — | US | disclosed |
| US-9302984-B2 | Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use | PIMCO 2664 LIMITED (GB) | 2016-04-05 | — | — | US | disclosed |
| US-20150266815-A1 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use | PIMCO 2664 LIMITED (GB) | 2015-09-24 | — | — | US | disclosed |
| US-9050329-B1 | Aryl-phenyl-sulfonamido-cycloalkyl compounds and their use | PIMCO 2664 LIMITED (GB) | 2015-06-09 | — | — | US | disclosed |
| US-20150141472-A1 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use | PIMCO 2664 LIMITED (GB) | 2015-05-21 | — | — | US | disclosed |
| US-20110172189-A1 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use | PIMCO 2664 LIMITED (GB) | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172189-A1 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use | SOST, AADAC, ARSA | KIF11 3109/4885MMP3 952/4885ALDH1A1 3408/4885 |
| US-20250242338-A1 | IRON PHOSPHIDE NANOPARTICLES, AND COMPOSITE BODY AND REDUCTION CATALYST EACH CONTAINING SAME | FECH, PI4K2A, PHOSPHO1 | KIF11 1434/4885MMP3 4687/4885ALDH1A1 4269/4885 |
| US-20150141472-A1 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use | SOST, AADAC, ARSA | KIF11 3055/4885MMP3 1011/4885ALDH1A1 3516/4885 |
| US-20150266815-A1 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use | SOST, AADAC, ARSA | KIF11 3055/4885MMP3 1011/4885ALDH1A1 3516/4885 |
| US-20160206578-A1 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use | SOST, AADAC, ARSA | KIF11 3055/4885MMP3 1011/4885ALDH1A1 3516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.